Pentazocine withdrawal in a Bahraini neonate

Abstract EN

A case of pentazocine withdrawal syndrome is described in a 5 days old Bahraini newborn whose mother had been taking pentazocine (Sosegon) for sickle cell disease vaso-occlusive crises.

The diagnosis was made on clinical grounds after and ruling out other causes of neonatal seizures and ,jitteriness by appropriate tests.

The baby was managed successfully with phenobarbitone over a 6 week period.

Follow up at و months 0،■ age showed normal growth and development.

High prevalence of sickle cell disease in Bahrain and wide spread use of analgesics warrants awareness of possible withdrawal syndrome ١١؛ infants of mothers who are on sedatives and analgesics such as pentazocine during pregnancy and labour.